Newlev (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which plays a key role in neurotransmitter release. By modulating SV2A, the drug stabilises neuronal firing and reduces abnormal excitability in the brain, thereby decreasing the likelihood of seizure activity.

The appropriate dose of Newlev is individualized by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Healthcare providers determine the exact regimen and any necessary adjustments during treatment.

The safety of levetiracetam in pregnancy and lactation has not been definitively established. Physicians should weigh potential benefits against unknown risks and discuss alternative options with patients who are pregnant, planning pregnancy, or breastfeeding.

To request Newlev, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with older agents such as carbamazepine or phenytoin, levetiracetam has a simpler pharmacokinetic profile, fewer drug‑enzyme interactions, and a lower risk of hepatic toxicity. However, individual response varies, and clinicians choose therapy based on seizure type, comorbidities and patient tolerance.

Newlev should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and excessive heat. Keep the product out of reach of children and avoid exposure to direct sunlight.

Newlev is taken orally, usually with or without food, as directed by the prescriber. The tablet (or other oral form) should be swallowed whole with a glass of water and not crushed or chewed unless specifically advised.

Serious adverse events include severe allergic reactions, Stevens‑Johnson syndrome, suicidal ideation, marked depression, blood dyscrasias, and multi‑organ hypersensitivity. Patients should seek immediate medical attention if they experience rash, mood changes, or signs of infection.

Newlev is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric disorders, or those taking interacting medications listed under major interactions.